Clinical Trial Update: Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)

View source ↗

Summary

A multi-center prospective trial evaluating outcomes in patients with moderate to severely calcified coronary lesions has completed, with results posted in 2019…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Abbott Medical Devices

Snippet

Sponsor: Abbott Medical Devices | Conditions: Coronary Artery Disease | Status: COMPLETED | Results posted: 2019-04-24